Get started
Author

Becky Nagy

Observed institution: Guardant (United States)
OpenAlex ID: A5041864269
Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer
2020 · Neelima Vidula, Taronish Dubash, et al. · Clinical Cancer Research · 27
Abstract A183: Blood-based genomic profiling of cell-free tumor DNA (ctDNA) in patients with biliary tract cancer
2018 · Lipika Goyal, Robin Kate Kelley, et al. · Molecular Cancer Therapeutics · 4
Abstract P5-13-29: Analytical and clinical validation of a ctDNA assay for detecting copy number loss and structural rearrangement variants contributing to homologous recombination and repair (HRR) deficiency
2022 · Jennifer Yen, Leylah Drusbosky, et al. · Cancer Research · 2
Abstract 401: Comparison of molecular response calculations for prediction of patient outcome
2021 · Allysia J. Mak, Katie J. Quinn, et al. · Cancer Research · 2
Supplementary Figure S1 from Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer
2023 · Neelima Vidula, Taronish Dubash, et al.
PDF
Supplementary Tables from Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer
2023 · Neelima Vidula, Taronish Dubash, et al.
PDF
Supplementary Figure S3 from Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer
2023 · Neelima Vidula, Taronish Dubash, et al.
PDF
Data from Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer
2023 · Neelima Vidula, Taronish Dubash, et al.
Data from Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer
2023 · Neelima Vidula, Taronish Dubash, et al.
Supplementary Figure S2 from Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer
2023 · Neelima Vidula, Taronish Dubash, et al.
Supplementary Figure S3 from Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer
2023 · Neelima Vidula, Taronish Dubash, et al.
Supplementary Figure S2 from Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer
2023 · Neelima Vidula, Taronish Dubash, et al.
PDF
Supplementary Tables from Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer
2023 · Neelima Vidula, Taronish Dubash, et al.
Supplementary Figure S1 from Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer
2023 · Neelima Vidula, Taronish Dubash, et al.
Abstract PD9-07: Genomic landscape of metastatic breast cancer (MBC): Comprehensive cell-free DNA analysis from over 10,000 patients and comparison with primary breast cancer
2021 · Aditya Bardia, Massimo Cristofanilli, et al. · Cancer Research
Abstract 729: Landscape of homologous recombination repair (HRR) mutations in prostate cancer profiled by ctDNA next-generation sequencing
2020 · Jennifer Yen, Sante Gnerre, et al. · Cancer Research
Abstract 4343: Comparison of over 10,000 clinical NGS circulating tumor DNA profiles to tissue-derived genomic compendia
2016 · Oliver A. Zill, Kimberly C. Banks, et al. · Cancer Research
Works count: 17
Citation count: 35
H-index: 2
I10-index: 1
Year
Topic
Type